Abdullah Sayied Abdullah

Abdullah Sayied Abdullah

Auto-generated profile, based on publicly available information

Abdullah Sayied Abdullah

Department of Cardiology, University Hospital Limerick, Limerick, Ireland

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2017 in Nature Ecology & Evolution
Verified
Journal Article
Closed access
PDF file
MRMartin K. Rono
Martin K. Rono
MNMary A. Nyonda
Mary A. Nyonda
JSJoan J. Simam
Joan J. Simam
JNJoyce M. Ngoi
Joyce M. Ngoi
SMSachel Mok
Sachel Mok
MMMargaret J. Mackinnon
Margaret J. Mackinnon

1 August 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AAAbdullah Abdullah
Abdullah Abdullah
GEGeorge Eigbire
George Eigbire
ASAmr Salama
Amr Salama
AWAbdul Wahab
Abdul Wahab
NNNinad Nadkarni
Ninad Nadkarni
RARichard Alweis
Richard Alweis

20 July 2018 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
AAAbdullah Abdullah
Abdullah Abdullah
GEGeorge Eigbire
George Eigbire
ASAmr Salama
Amr Salama
AWAbdul Wahab
Abdul Wahab
MAMohanad Awadalla
Mohanad Awadalla
RARichard Alweis
Richard Alweis
Background: Delirium is associated with worse outcomes in critically ill patients. In the subset of patients with myocardial infarction (MI), the impact on clinical outcomes of delirium is not as well elucidated.Hypothesis: Delirium is associated with increased mortality in patients hospitalized for MI.Methods: The study used data from the National Inpatient Sample 2012 to 2014, Healthcare Cost and Utilization Project. We included discharges associated with the primary diagnosis of MI using the relevant International Classification of Diseases, Ninth Revision, Clinical Modification codes. The outcome was inpatient mortality between the delirium group and propensity score–matched controls without delirium.Results: The study included 1 330 020 weighted discharges with MI as the principal diagnosis. Within this cohort, 18 685 discharges (1.4%) had delirium. Delirium was associated with older age, lower rates of percutaneous coronary intervention, and increased comorbid conditions. The delirium group had higher mortality (10.5% vs 2.6%, P < 0.001). Propensity score–matching analysis showed increased mortality in the delirium group (10.5% vs 7.6%, relative risk: 1.39 [95% confidence interval: 1.2–1.6, P < 0.001) using nearest neighbor 1:1 matching.Conclusions: In individuals with MI, delirium was associated with increased inpatient mortality.

24 November 2018 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
ASAmr Salama
Amr Salama
AAAbdullah Abdullah
Abdullah Abdullah
AWAbdul Wahab
Abdul Wahab
GEGeorge Eigbire
George Eigbire
RHRyan Hoefen
Ryan Hoefen
RARichard Alweis
Richard Alweis
Background: Obstructive sleep apnea (OSA) is a known independent risk factor for a multiple cardiovascular morbidities and mortality. The association of OSA and ventricular arrhythmias is less well understood. The aim of this analysis is to study the relationship between OSA and ventricular tachyarrhythmias.Hypothesis: OSA is associated with increased ventricular arrhythmias.Methods: Data from the national inpatient sample (NIS) 2012 to 2014, were reviewed. Discharges associated with OSA were identified as the target population using the relevant ICD‐9‐CM codes. The primary outcome was a diagnosis of ventricular tachycardia (VT) in the OSA population. Secondary outcomes include the rate of ventricular fibrillation (VF) and cardiac arrest. Multivariable analyses were performed to examine the association of VT with multiple potential confounding clinical variables.Results: Of 18 013 878 health encounters, 943 978 subjects (5.24%) had a diagnosis of OSA. VT and VF were more prevalent among patients with OSA compared to those without a diagnosis of OSA (2.24% vs 1.16%; P < 0.001 and 0.3% vs 0.2%; P < 0.001, respectively). Odds ratio for cardiac arrest in OSA group was not statistically significant (1, 95% confidence interval 0.97‐1.02, P < 0.76). In unadjusted analyses, all examined comorbidities were significantly more common in those with OSA, including diabetes mellitus, hypertension, chronic kidney disease, acute coronary syndrome, and heart failure.Conclusion: OSA is associated with increased rates of ventricular tachyarrhythmia.

21 June 2020 in Cardiology Journal
Verified
Journal Article
Open access
PDF file
ASAmr Salama
Amr Salama
AAAbdullah Abdullah
Abdullah Abdullah
AWAbdul Wahab
Abdul Wahab
GEGeorge Eigbire
George Eigbire
RHRyan Hoefen
Ryan Hoefen
RARichard Alweis
Richard Alweis
Background: Sarcoidosis is an increasingly recognized multi-systemic condition. Cardiac sarcoidosis is associated with ventricular arrhythmias and higher mortality rates. Little epidemiological data is available regarding the disease and associated ventricular arrhythmias. Methods: Data from the National Inpatient Sample (NIS) database 2012–2014, were reviewed. Discharges associated with sarcoidosis were identified as the target population using relevant ICD-9-CM codes. Primary outcome was a diagnosis of ventricular tachycardia (VT) in the sarcoidosis population. Secondary outcomes include rate of ventricular fibrillation (VF) and cardiac arrest. Subgroup analyses were performed to examine the association of VT with multiple potential confounding clinical variables. Results: Of 18,013,878 health encounters, 46,289 (0.26%) subjects had a diagnosis of sarcoidosis. VT and VF were more prevalent among patients with sarcoidosis compared to those without a diagnosis of sarcoidosis (2.29% vs. 1.22%; p < 0.001 and 0.25% vs. 0.21%; p < 0.001, respectively). Sarcoidosis was also associated with a higher prevalence of cardiac arrest (0.72% vs. 0.6%; p < 0.001). In unadjusted analyses, all examined comorbidities were significantly more common in those with sarcoidosis, including diabetes mellitus (31.6% vs. 21.25%; p < 0.001), hypertension (65.2% vs. 51.74%; p < 0.001), chronic kidney disease (21.09% vs. 14.02%; p < 0.001), heart failure (24.87% vs. 15%; p < 0.001) and acute coronary syndrome (ACS) (4.32% vs. 3.35%; p < 0.001). Conclusions: The present study showed that sarcoidosis was associated with increased rates of ventricular tachyarrhythmia, which can affect the overall disease morbidity and mortality. Background: Sarcoidosis is an increasingly recognized multi-systemic condition. Cardiac sarcoidosis is associated with ventricular arrhythmias and higher mortality rates. Little epidemiological data is available regarding the disease and associated ventricular arrhythmias. Methods: Data from the National Inpatient Sample (NIS) database 2012–2014, were reviewed. Discharges associated with sarcoidosis were identified as the target population using relevant ICD-9-CM codes. Primary outcome was a diagnosis of ventricular tachycardia (VT) in the sarcoidosis population. Secondary outcomes include rate of ventricular fibrillation (VF) and cardiac arrest. Subgroup analyses were performed to examine the association of VT with multiple potential confounding clinical variables. Results: Of 18,013,878 health encounters, 46,289 (0.26%) subjects had a diagnosis of sarcoidosis. VT and VF were more prevalent among patients with sarcoidosis compared to those without a diagnosis of sarcoidosis (2.29% vs. 1.22%; p < 0.001 and 0.25% vs. 0.21%; p < 0.001, respectively). Sarcoidosis was also associated with a higher prevalence of cardiac arrest (0.72% vs. 0.6%; p < 0.001). In unadjusted analyses, all examined comorbidities were significantly more common in those with sarcoidosis, including diabetes mellitus (31.6% vs. 21.25%; p < 0.001), hypertension (65.2% vs. 51.74%; p < 0.001), chronic kidney disease (21.09% vs. 14.02%; p < 0.001), heart failure (24.87% vs. 15%; p < 0.001) and acute coronary syndrome (ACS) (4.32% vs. 3.35%; p < 0.001). Conclusions: The present study showed that sarcoidosis was associated with increased rates of ventricular tachyarrhythmia, which can affect the overall disease morbidity and mortality.

1 August 2019 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
ASAhmed Subahi
Ahmed Subahi
AAAbdullah Abdullah
Abdullah Abdullah
AYAhmed S. Yassin
Ahmed S. Yassin
HAHossam Abubakar
Hossam Abubakar
AAAshraf Abugroun
Ashraf Abugroun
TMTamam Mohamad
Tamam Mohamad